Dougherty & Co Starts Sequenom (SQNM) at Buy; See MaterniT21 Becoming the New Gold Standard of Care in Down Syndrome Testing
Go back to Dougherty & Co Starts Sequenom (SQNM) at Buy; See MaterniT21 Becoming the New Gold Standard of Care in Down Syndrome Testing| Sequenom, Inc. (NASDAQ: SQNM) | Delayed: 2.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.39 | 52 Week High | $2.53 | |||
| Open | $9.75 | 52 Week Low | $0.82 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.39 | EPS | $-1.05 | |||
| Volume | 355,082 | |||||
